                         SEQUENCE LISTING

<110>  Sapreme Technologies B.V.
       Charit - UNIVERSITTSMEDIZIN BERLIN
 
<120>  ANTIBODY-DRUG CONJUGATE WITH IMPROVED THERAPEUTIC WINDOW

<130>  P6089257PCT

<140>  PCT/EP2019/084180
<141>  2019-12-09

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  DNA
<213>  Antisense BNA (HSP27) oligo nucleic acid sequence

<400>  1
ggcacagcca gtggcg                                                       16


<210>  2
<211>  18
<212>  DNA
<213>  UBC primer forward sequence

<400>  2
cagccgggat ttgggtcg                                                     18


<210>  3
<211>  23
<212>  DNA
<213>  UBC primer reverse sequence

<400>  3
cacgaagatc tgcattgtca agt                                               23


<210>  4
<211>  20
<212>  DNA
<213>  GUSB primer forward sequence

<400>  4
tgcgtaggga caagaaccac                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  GUSB primer reverse sequence

<400>  5
gggaggggtc caaggatttg                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  IMMT primer forward sequence

<400>  6
aacccacacc tgcactttca                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  IMMT primer reverse sequence

<400>  7
ttttcctgtt gtgcaaggcg                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  EIF2S2 primer forward sequence

<400>  8
ccacaagtcg tccgagtagg                                                   20


<210>  9
<211>  20
<212>  DNA
<213>  EIF2S2 primer reverse sequence

<400>  9
ggagatgttt gggctgacga                                                   20


<210>  10
<211>  20
<212>  DNA
<213>  HSP27 primer forward sequence

<400>  10
gcagtccaac gagatcacca                                                   20


<210>  11
<211>  20
<212>  DNA
<213>  HSP27 primer reverse sequence

<400>  11
taaggcttta cttggcggca                                                   20


<210>  12
<211>  18
<212>  PRT
<213>  Customized peptide

<400>  12

Ser Glu Ser Asp Asp Ala Met Phe Cys Asp Ala Met Asp Glu Ser Asp 
1               5                   10                  15      


Ser Lys 
        


